Regaine For Men 5% Foam - 6 Month Supply

In stock

Estimate Shipping Time:

Brand: Regaine

Price:

€111.00 /3x73ml Bottle | x2 Pack

Regaine for Men Extra Strength Scalp Foam is a medicine used to treat hereditary hair loss in men aged 18 – 49 years, by preventing further hair loss and helping re-growth. It contains minoxidil, which is thought to work by aiding the blood flow to the hair follicles on your scalp.

The medicine is only for use in men aged between 18 and 49 years.

Regaine for Men Extra Strength Scalp Foam works best in men with hair loss or thinning at the top of the scalp.

Those who are younger, have been losing hair for a short period of time or have a small area of baldness are likely to experience the best results.

Approved by Emma Harrison- Accuracy checking technician on the 17/10/2022.
For more information, view our medical team

You are unlikely to benefit from Regaine for Men Extra Strength Scalp Foam if you have been bald for many years or have a large area of hair loss.

Hereditary hair loss is recognisable because:

Of the pattern of hair loss.

It starts gradually and progresses.

You have a family history of hair loss

No other symptoms are present with your hair loss.

What the medicine looks like

Regaine for Men Extra Strength Scalp Foam is a foam contained in a 73 ml (equivalent to a 60 g) can, enough for 6 month of treatment. Packs contain 1 or 3 cans.

Regaine for Men Extra Strength Scalp Foam is for topical and external use only. It should only be applied directly to the scalp area.

This medicine is suitable for most people but a few people should not use it. If you are in any doubt, talk to your doctor or pharmacist.

Like all medicines, this medicine can cause side-effects, although not everybody gets them.

If you experience any of the following, stop using the medicine and seek immediate medical help:

Chest pain.
Swelling of the face, lips, mouth, tongue or throat which may cause difficulty in swallowing or breathing.

If you experience any of the following, stop using the medicine and talk to your doctor:

Allergic reactions including swollen face, skin redness or itching or throat tightness.
Low blood pressure.
Fast heart beat or an increased awareness of the heart beat (palpitations).
Faintness or dizziness.
Swollen hands or feet, shortness of breath.
Sudden unexplained weight gain.
Persistent local redness or rash.

Other effects which may occur, include:

Very common (may affect more than 1 in 10 people)

Headache

Common (may affect up to 1 in 10 people)

Itching or dermatitis.
Unwanted non scalp hair has been reported (including facial hair growth in women). Always wash your hands thoroughly after application and if you accidentally apply the foam to parts of your body other than the scalp, rinse thoroughly with plenty of water.

Uncommon (may affect up to 1 in 100 people).

Nausea.

Rare (may affect up to 1 in 1,000 people)

Change in hair texture may occur. If this happens you should stop using Regaine.

Other effects which may occur but it is not know how often:

Depressed mood.
Eye irritation.
Vomiting
Scalp irritation such as local redness, dryness, flaky skin have all been reported. This may be due to the hydroxybutylated toluene, cetyl alcohol and / or stearyl alcohol in the product. This is usually only a temporary effect, but if it is persistent you should stop using this product.
Acne like rash, itchy rash, blistering, bleeding or ulceration.
Temporary hair loss may occur during the first 2-6 weeks of use. This is likely to be as a result of a change within the growth cycle and it should stop within a couple of weeks. If this hair loss continues for longer than 2 weeks, stop using the product and talk to your doctor.
Change in hair colour may occur. If this happens you should stop using Regaine.

If you experience any side-effects talk to your doctor, pharmacist or nurse. This includes any possible side effects not included in this leaflet. You can also report any side effects directly via the Yellow Card Scheme at:

www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

And in Malta directly via

ADR Reporting, The Medicines Authority, Post-Licensing Directorate, 203 Level 3, Rue D'Argens, GZR-1368 Gzira.

website: www.medicinesauthority.gov.mt

email: postlicensing.medicinesauthority@gov.mt

By reporting side effects, you can help provide more information on the safety of this medicine.